trial · primary record
TRB191
Extensive-stage Small Cell Lung Cancer
| Phase | Phase 1 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 120 |
| Primary completion | 2030-08-06 |
| Primary endpoint | Incidence and severity of Adverse Events (AEs) and Serious Adverse Events (SAEs) |
| Registry ID | NCT07908667 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-02T15:44:23.979Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07908667
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.